Plant Profile

Rhodiola Rosea

Rhodiola rosea
Family: Crassulaceae  ·  Parts used: Rhizome, Root  ·  Also known as: Rhodiola, golden root, roseroot, Arctic root

The complete database record: 3 documented constituents, 6 pharmacological actions, 11 traditional / indicated uses, with 19 cited sources.

Botanical Description

Succulent perennial herb (Crassulaceae), 15-40 cm tall, with a thick, fleshy, branching rhizome that has a rose-like fragrance when cut - the origin of the name 'rosea'. Leaves are fleshy, greyish-green, oval to oblong. Small yellow (occasionally reddish) flowers are clustered in dense terminal heads; the species is dioecious, with separate male and female plants. Fruit follicles turn red as they ripen.[3]

Height: 15-40 cm
Habit: Succulent perennial herb, dioecious
Leaves: Fleshy, greyish-green, oval to oblong
Flowers: Small, yellow (occasionally reddish), in dense terminal clusters
Stem: Erect, succulent
Root: Thick, fleshy, branching rhizome, rose-scented when cut
Fruit: Follicles, turning red as they ripen
Flowering Period: June-July

Habitat & Distribution

Native to arctic and mountainous regions of Europe, Asia and North America (circumpolar), growing in cold, rocky, high-altitude or high-latitude terrain - cliffs, rocky slopes and tundra - tolerating harsh, exposed conditions.[3]

Harvesting

Rhizome and root are dug from plants at least a few years old (traditionally 4-5 years), typically in autumn, then cleaned and dried. Wild populations grow slowly, so cultivated sources are increasingly preferred for sustainability.[3]

Parts: Rhizome, Root
Season: Autumn, from plants at least 4-5 years old

Key Constituents

Rosavins (rosavin, rosarin, rosin)[3]

Characteristic phenylpropanoid glycosides largely unique to Rhodiola rosea, used as a standardisation marker for commercial extracts.

Salidroside and tyrosol[3]

Phenylethanoid glycosides considered key adaptogenic and antioxidant constituents.

Phenylpropanoids and flavonoids[2]

Contribute to the anti-inflammatory and antioxidant activity of the root.

Flavonoids

Pharmacological Actions

Anti-inflammatory[2, 3, 9, 13, 14]
Antidiabetic (blood-sugar lowering)[3, 13, 14]
Antioxidant[3, 13, 14]
Physical performance / ergogenic[3, 4, 13, 14]

Physical performance / strength improvement

Immunomodulator / immune support[3, 13, 14]
Neuroprotective / cognition support[3, 10, 13, 14]

Traditional & Indicated Uses

Arthritis / joint pain[3, 14]Preliminary · 2/10

inferred from anti-inflammatory action

Mechanistic Exclude Ids: REF-0055, REF-1534
Evidence: 2
Label: Arthritis / joint pain

more plants for arthritis / joint pain →detailed sources →

Blood sugar / diabetes support[3, 14]Preliminary · 2/10

inferred from antidiabetic action

Mechanistic Exclude Ids: REF-0055
Evidence: 2
Label: Blood sugar / diabetes support

more plants for blood sugar / diabetes support →detailed sources →

Cognitive function[3, 5, 13, 14]Moderate · 6/10

inferred from neuroprotective action

Mechanistic Exclude Ids: REF-1535
Evidence: 6
Label: Cognitive function

more plants for cognitive function →detailed sources →

Cold & flu[3, 14]Preliminary · 2/10

inferred from immunomodulator action

Mechanistic Exclude Ids: REF-0055
Evidence: 2
Label: Cold & flu

more plants for cold & flu →detailed sources →

Fatigue / low energy[1, 3, 4, 7, 8, 13, 14]Strong · 10/10

inferred from ergogenic action

Evidence: 10
Label: Fatigue / low energy

more plants for fatigue / low energy →detailed sources →

Immune support[3, 14]Preliminary · 2/10
Mechanistic Exclude Ids: REF-0055
Evidence: 2
Label: Immune support

more plants for immune support →detailed sources →

Inflammation (general)[2, 3, 9, 14]Good · 7/10

inferred from anti-inflammatory action

Mechanistic Exclude Ids: REF-0055
Evidence: 7
Label: Inflammation (general)

more plants for inflammation (general) →detailed sources →

Memory[3, 13, 14]Moderate · 5/10

inferred from neuroprotective action

Mechanistic Exclude Ids: REF-1535
Evidence: 5
Label: Memory

more plants for memory →detailed sources →

Metabolic support[3, 14]Preliminary · 2/10
Mechanistic Exclude Ids: REF-0055
Evidence: 2
Label: Metabolic support

more plants for metabolic support →detailed sources →

Muscle soreness[3, 4, 14]Good · 7/10

inferred from ergogenic action

Mechanistic Exclude Ids: REF-0055
Evidence: 7
Label: Muscle soreness

more plants for muscle soreness →detailed sources →

Skin irritation[3, 14]Preliminary · 2/10

inferred from anti-inflammatory action

Mechanistic Exclude Ids: REF-0055, REF-1534
Evidence: 2
Label: Skin irritation

more plants for skin irritation →detailed sources →

Traditional Use & History

Rhodiola has a long tradition of use across Scandinavian, Russian and Central Asian folk medicine as a tonic for cold-climate hardiness, physical endurance and mental stamina. It is classified as a modern 'adaptogen', and clinical trials support benefits for stress-related fatigue, mood and cognitive performance.[1, 3]

Preparations

Standardised root extract (capsule)[7, 8]

Standardised to rosavins and salidroside (commonly the SHR-5 extract), the form used in most clinical trials.

Dosage

Standardised extract[7, 8]

Clinical trials have most often used 340-680 mg/day of standardised root extract (e.g. SHR-5, standardised to rosavins/salidroside), typically taken in the morning to avoid overstimulation. Educational reference only, not a prescription.

Safety, Cautions & Contraindications

Safety note[3, 13, 14]Caution

Generally well tolerated. May cause agitation, insomnia, or vivid dreams in sensitive individuals - take in the morning. Avoid in manic episodes or severe anxiety. Theoretical interactions with MAOIs, SSRIs, and CNS stimulants. Avoid during pregnancy and breastfeeding.

Safety note[3, 13, 14, 15]Info

Duke (2002) does not include a dedicated entry for Rhodiola rosea in the Handbook of Medicinal Herbs, Second Edition.

Herb-Drug Interactions

Antidepressants Serotonergic[16, 17]Caution
Mechanism: Rhodiola inhibits monoamine oxidase (MAO-A/B) and raises serotonin and dopamine activity; a case report described serotonergic-syndrome-type symptoms (restlessness, trembling) when rhodiola was added to the antidepressant paroxetine. Combined with antidepressants it may add to serotonergic effects.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03

Herb-Herb Pairings

Siberian Ginseng[18, 19]

Rhodiola and eleuthero (Siberian ginseng) are classic adaptogens combined in traditional and studied fixed formulas to build resistance to stress and fatigue; used together their stress-protective effects are complementary.

Type: synergy
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Schisandra[18, 19]

Rhodiola and schisandra are adaptogens co-formulated in clinically studied combinations for stress, fatigue and mental performance; combined use is intended to be synergistic rather than harmful.

Type: synergy
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03

Harvest Readiness

[11, 12]

Part: rhizome
Signals: Lift only from mature plants: the underground parts are dug once, at the end of the fourth or fifth year of growth., Within a season the rosavin content of the dried rhizome is at its highest at flowering.
Basis: both
Constituent Note: Total rosavins in the dried rhizome peak at flowering, and root dry weight falls to a minimum at budding/full flowering before rising again towards a harvest taken after wilting (ISHS Acta Horticulturae, REF-3385).
Source Quote: Rhodiola rosea is grown as a perennial, but the roots are harvested once at the end of four or five years.
Species Confirmed: 1
Notes: Two complementary sources, not one confirming the other, which is why this stays provisional. Alberta Agriculture Agdex 188/20-2 (REF-3384) gives the maturity rule (fourth or fifth year); the ISHS harvest-time study (REF-3385) gives the within-season phenophase - 'The content of total rosavins in the dry rhizomes was the highest at flowering on both sites'. They address different aspects of readiness and so do not constitute an independent confirmation of the same stage. Supersedes the earlier dead end (PFAF and Useful Temperate Plants gave only flowering and propagation-division timing).

[11, 12]

Part: root
Signals: The root is dug with the rhizome, from mature plants only, at the end of the fourth or fifth year of growth., Root dry weight falls to a minimum around budding and full flowering, then rises again towards a harvest taken after the tops have wilted.
Basis: both
Constituent Note: Rhizomes of R. rosea contain more phenylpropenoids than the roots, and root dry weight is lowest at budding/full flowering, recovering towards the post-wilting harvest (ISHS Acta Horticulturae, REF-3385).
Source Quote: the dry weight of the root decreased until budding/full flowering, followed by an increase towards the last harvest after wilting
Species Confirmed: 1
Notes: ISHS harvest-time study of cultivated Rhodiola rosea at Finnish and Norwegian sites (REF-3385) for the within-season phenophase, plus Alberta Agriculture Agdex 188/20-2 (REF-3384) for the maturity rule, 'the roots are harvested once at the end of four or five years'. The two sources are complementary rather than confirmatory, so this stays provisional. Supersedes the earlier dead end.

External Identifiers

References & Sources

  1. Ivanova Stojcheva, E. and Quintela, J.C (2022) 'The Effectiveness of Rhodiola rosea L. Preparations in Alleviating Various Aspects of Life-Stress Symptoms and Stress-Induced Conditions - Encouraging Clinical Evidence', Molecules, 27(12), pp. 3902. doi:10.3390/molecules27123902 Meta-analysis / review
    https://doi.org/10.3390/molecules27123902
  2. Pu, W.L., Zhang, M.Y., Bai, R.Y., Sun, L.K. and others (2019) 'Anti-inflammatory effects of Rhodiola rosea L.: A review', Biomedicine & Pharmacotherapy, 121, pp. 109552. doi:10.1016/j.biopha.2019.109552 Meta-analysis / review
    https://doi.org/10.1016/j.biopha.2019.109552
  3. Panossian, A., Wikman, G. and Sarris, J (2010) 'Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy', Phytomedicine, 17(7), pp. 481-493. doi:10.1016/j.phymed.2010.02.002 Preclinical
    https://doi.org/10.1016/j.phymed.2010.02.002
  4. Tinsley, G.M., Jagim, A.R., Potter, G.D.M., Garner, D. and Galpin, A.J (2023) 'Rhodiola rosea as an adaptogen to enhance exercise performance: a review of the literature', The British Journal of Nutrition, 131(3), pp. 461-473. doi:10.1017/S0007114523001988 Meta-analysis / review
    https://doi.org/10.1017/S0007114523001988
  5. Cropley, M., Banks, A.P. and Boyle, J (2015) 'The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms', Phytotherapy Research, 29(12), pp. 1934-1939. doi:10.1002/ptr.5486 Randomized trial
    https://doi.org/10.1002/ptr.5486
  6. Amsterdam, J.D. and Panossian, A.G (2016) 'Rhodiola rosea L. as a putative botanical antidepressant', Phytomedicine, 23(7), pp. 770-783. doi:10.1016/j.phymed.2016.02.009 Meta-analysis / review
    https://doi.org/10.1016/j.phymed.2016.02.009
  7. Olsson, E.M., von Scheele, B. and Panossian, A.G (2009) 'A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue', Planta Medica, 75(2), pp. 105-112. doi:10.1055/s-0028-1088346 Randomized trial
    https://doi.org/10.1055/s-0028-1088346
  8. Ishaque, S., Shamseer, L., Bukutu, C. and Vohra, S (2012) 'Rhodiola rosea for physical and mental fatigue: a systematic review', BMC Complementary and Alternative Medicine, 12, pp. 70. doi:10.1186/1472-6882-12-70 Meta-analysis / review
    https://doi.org/10.1186/1472-6882-12-70
  9. Borgonetti, V., Governa, P., Biagi, M., Dalia, P. and Corsi, L (2019) 'Rhodiola rosea L. modulates inflammatory processes in a CRH-activated BV2 cell model', Phytomedicine, 68, pp. 153143. doi:10.1016/j.phymed.2019.153143 Preclinical
    https://doi.org/10.1016/j.phymed.2019.153143
  10. Coors, A., Brosch, M., Kahl, E., Khalil, R. and others (2019) 'Rhodiola rosea root extract has antipsychotic-like effects in rodent models of sensorimotor gating', Journal of Ethnopharmacology, 235, pp. 320-328. doi:10.1016/j.jep.2019.02.031 Preclinical
    https://doi.org/10.1016/j.jep.2019.02.031
  11. Alberta Agriculture and Rural Development (2010) 'Rhodiola rosea: A High Value Crop (Agdex 188/20-2)'. Available at: https://www1.agric.gov.ab.ca/$department/deptdocs.nsf/all/agdex13054/$file/188_20-2.pdf Traditional / reference
    https://www1.agric.gov.ab.ca/$department/deptdocs.nsf/all/agdex13054/$file/188_20-2.pdf
  12. International Society for Horticultural Science 'Harvest time and drying temperature effect on secondary metabolites in Rhodiola rosea', Acta Horticulturae, (955), pp. 245--250. Available at: https://ishs.org/ishs-article/955_35/ Preclinical
    https://ishs.org/ishs-article/955_35/
  13. Darbinyan, V. et al (2000) 'Rhodiola rosea in stress induced fatigue — a double blind cross-over study of a standardized extract SHR-5', 7(5), pp. 365--371. Randomized trial
    https://scholar.google.com/scholar?q=Rhodiola%20rosea%20in%20stress%20induced%20fatigue%20%E2%80%94%20a%20double%20blind%20cross-over%20study%20of%20a%20standardized%20extract%20SHR-5
  14. Kelly, G.S (2001) 'Rhodiola rosea: a possible plant adaptogen', 6(3), pp. 293--302. Traditional / reference
    https://scholar.google.com/scholar?q=Rhodiola%20rosea%3A%20a%20possible%20plant%20adaptogen
  15. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
  16. Maniscalco, I., Toffol, E., Giupponi, G. and Conca, A (2014) 'The interaction of Rhodiola rosea and antidepressants. A case report', Neuropsychiatrie, 29(1), pp. 36-38. doi:10.1007/s40211-014-0124-8 Clinical study
    https://doi.org/10.1007/s40211-014-0124-8
  17. van Diermen, D., Marston, A., Bravo, J., Reist, M., Carrupt, P.A. and Hostettmann, K (2009) 'Monoamine oxidase inhibition by Rhodiola rosea L. roots', Journal of Ethnopharmacology, 122(2), pp. 397-401. doi:10.1016/j.jep.2009.01.007 Preclinical
    https://doi.org/10.1016/j.jep.2009.01.007
  18. Panossian, A.G (2013) 'Adaptogens in mental and behavioral disorders', Psychiatric Clinics of North America, 36(1), pp. 49-64. doi:10.1016/j.psc.2012.12.005 Meta-analysis / review
    https://doi.org/10.1016/j.psc.2012.12.005
  19. Karosanidze, I., Kiladze, U., Kirtadze, N., Giorgadze, M. and Panossian, A (2022) 'Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial', Pharmaceuticals, 15(3), pp. 345. doi:10.3390/ph15030345 Randomized trial
    https://doi.org/10.3390/ph15030345

This fact sheet is generated automatically from the Omnia Sana plant database and reflects its latest synced data. It is provided for educational purposes only and is not medical advice. How this site is built.

Selected studies & references

Educational use only. This profile summarises traditional and scientific sources for reference. It is not medical advice and not a substitute for a qualified practitioner. Some plants carry safety cautions and drug interactions - always check before use.
This profile is assembled automatically from the Omnia Sana plant database, which we curate by hand. How this site is built.
← Browse all plants